Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-04

Clinical Trial Update: An Adaptive Randomized Controlled Trial [NA]

View source ↗

Summary

Columbia University sponsors an adaptive randomized controlled trial protocol that is currently recruiting. The study targets multidrug-resistant tuberculosis a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Columbia University | Conditions: Multi Drug Resistant Tuberculosis, HIV Infections | NA | Status: RECRUITING